Literature DB >> 16330532

Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation.

Shuli Zhang1, Joseph H Phillips.   

Abstract

CD200 and its receptor CD200R are type-1 membrane glycoproteins, which contain two immunoglobulin-like domains. Engagement of CD200R by CD200 inhibits activation of myeloid cells. Unlike the majority of immune inhibitory receptors, CD200R does not contain an immunoreceptor tyrosine-based inhibitory motif but contains three tyrosine residues (Y286, Y289, and Y297) in the cytoplasmic domain. Y297 is located in an NPxY motif. Previously, we have shown that engagement of CD200R in mouse mast cells induces its tyrosine phosphorylation and recruitment of inhibitory adaptor proteins Dok1 and Dok2, leading to the inhibition of Ras/mitogen-activated protein kinase activation. In the present study, we examined the roles of these three tyrosines in CD200R-mediated inhibition by site-directed mutagenesis in mouse mast cells. Our data show that Y286 and Y297 are the major phosphorylation sites and are critical for CD200R-mediated inhibition of mast cell activation, and Y289 is dispensable. Our data also suggest that the Src family kinase may mediate the phosphorylation of CD200R and Dok.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330532     DOI: 10.1189/jlb.0705398

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  18 in total

1.  Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.

Authors:  Robin Mihrshahi; Marion H Brown
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

Review 2.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 3.  Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles.

Authors:  Xiaoming Hu; Anthony K F Liou; Rehana K Leak; Mingyue Xu; Chengrui An; Jun Suenaga; Yejie Shi; Yanqin Gao; Ping Zheng; Jun Chen
Journal:  Prog Neurobiol       Date:  2014-06-09       Impact factor: 11.685

4.  Membrane-associated and secreted forms of the Rhesus macaque rhadinovirus-encoded CD200 homologue and cellular CD200 demonstrate differential effects on Rhesus Macaque CD200 Receptor signaling and regulation of myeloid cell activation.

Authors:  Ryan D Estep; Aparna N Govindan; Kristin Fitzpatrick; Tiffany C Blair; S A Rahim Rezaee; David J Blackbourn; Scott W Wong
Journal:  J Virol       Date:  2020-12-16       Impact factor: 5.103

Review 5.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

6.  Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.

Authors:  Robin Mihrshahi; A Neil Barclay; Marion H Brown
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

Review 7.  Negative signaling by inhibitory receptors: the NK cell paradigm.

Authors:  Eric O Long
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

8.  CD200 receptor controls sex-specific TLR7 responses to viral infection.

Authors:  Guruswamy Karnam; Tomasz P Rygiel; Matthijs Raaben; Guy C M Grinwis; Frank E Coenjaerts; Maaike E Ressing; Peter J M Rottier; Cornelis A M de Haan; Linde Meyaard
Journal:  PLoS Pathog       Date:  2012-05-17       Impact factor: 6.823

Review 9.  Introduction to DOK2 and its potential role in cancer.

Authors:  P Sun; R Li; Y Meng; S Xi; Q Wang; X Yang; X Peng; J Cai
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

10.  Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival.

Authors:  Aaron Prodeus; Marzena Cydzik; Aws Abdul-Wahid; Eric Huang; Ismat Khatri; Reginald Gorczynski; Jean Gariépy
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-26       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.